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clinical data were unknown. On the same day,
we contacted and interviewed the patient to
investigate risk factors for cholera. The patient
reported abdominal pain starting on 6 June and
then severe diarrhea (10 to 12 stools per day)
until 13 June; on that day the patient went to his
general practitioner, who gave him loperamide
and suggested a coproculture. The patient never
traveled to cholera-endemic areas; did not eat
raw mussels, uncooked fish, or vegetables of
uncertain origin or from cholera-infected areas;
and did not swim in rivers or lakes. The patient
reported that he ate a seafood salad in the
canteen of his work place on 5 June and that
three out of the four persons who ate the same
kind of salad also had abdominal symptoms.
Subsequently, the Istituto Superiore di Sanità
(ISS) in Rome confirmed isolation of toxinogenic
V. cholerae O1, biotype El Tor, serotype Ogawa,
from stools from the index patient.
The canteen where the index patient had
eaten the seafood salad was 1 of 17 supplied by a
single cooking center that used a precooked,
frozen, ready-to-eat product including shrimps,
scallops, mussels, hen clams, cuttlefishes, and
squid. Each product was cooked and frozen in the
country of origin and mixed in Italy by an
importer who packaged the seafood salad.
Tracking the products around the world was
difficult, but we learned that at least some had
come from Far East countries where cholera is
endemic. Approximately 125 servings of the
same food were distributed within our local
public health area (Azienda Sanitaria Locale)
and more than 400 in other areas.
We performed an epidemiologic case-control
investigation beginning 18 June involving 454
persons (94 who had eaten the seafood salad and
360 controls who had eaten in the same canteen
any food except seafood salad); 37 (39%) of the
persons who had eaten the seafood salad had had
at least one episode of diarrhea or other relevant
gastrointestinal symptoms, as compared to one
(0.3%) of those who had not eaten it. We did not
find symptomatic patients. The corresponding
odds ratio was 233 (95% confidence interval, 97
to 560). No symptomatic person had to be
hospitalized because of symptoms or required
intravenous treatment; three or more loose or
watery stools during a 24-hour period were
reported in 24 cases. We performed coprocultures
(using TCBS medium) between 23 June and 3
July of all 94 persons who had eaten the seafood
salad. One positive coproculture for V. cholerae
O1 Ogawa (same strain) was identified on 25
June;  the isolation was subsequently confirmed
by the ISS. This second patient with a positive
culture  worked in a factory in a different town.
She had severe diarrhea on 6, 7, and 8 June. Her
family doctor gave her rifaximin but did not ask
for a coproculture, but a specimen was obtained
on 23 June. She did not report risk factors for
cholera infection, except having eaten seafood
salad on June 5 in the canteen of her work place.
The delay between exposure to V. cholerae and
the coprocultures was longer than 1 week
(median delay 26 days, range 19 to 31), and it is
therefore not surprising that others who had
eaten the seafood salad did not have positive
results. Both the culture-positive index case-
patient and the woman were recultured three
more times; negative results were obtained.
The identification of this cholera outbreak is
a sentinel episode confirming (1,2) that, if not
adequately monitored, food preparation and
distribution can cause serious infectious diseases
in industrialized countries.
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Shiga Toxin–Producing Escherichia coli
O157:H7 in Japan
To the Editor: Shiga toxin-producing Escheri-
chia coli (STEC) O157:H7 infection, which can
cause hemolytic uremic syndrome and death, is a
global public health concern. Patients younger
than 5 years of age are at high risk for hemolytic
uremic syndrome (1) and shed the organism
longer than adults (2). The public health302 Emerging Infectious Diseases Vol. 5, No. 2, MarchApril 1999
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importance of this symptomatic shedding in
transmission among preschool children is well
established (3); however, that of symptom-free
shedding in adults is unknown. We report here
that the rate of symptom-free STEC O157:H7
shedding is higher in adults 30 to 49 years of age
than in others.
STEC infections have been notifiable in
Japan since August 1996. When STEC is found
in the feces of patients in schools, families, and
hospitals, local health centers and public health
institutes must test (generally using MacConkey
sorbitol agar with cefixime-potassium tellurite
medium) for the pathogen in stool specimens of
contacts of the patients. The pathogen is also
sought twice a month in the stool specimens of
food-handlers. All isolates from culture-positive
patients are collected by Japans National
Institute of Infectious Diseases.
In 1997, 1,412 STEC O157:H7 human
isolates were examined  for subtyping of Shiga
toxin genes stx1 and stx2 by polymerase chain
reaction, for genotyping by XbaI-digested
pulsed-field gel electrophoresis (PFGE) (4,5),
and for their relationship with symptoms; 1,381
isolates (from culture-positive persons with well-
characterized clinical status) were further
analyzed. The rates by age group among STEC
O157:H7-shedding persons reporting one or
more symptoms (vs. culture-positive persons
without symptoms) were as follows: 82% (475 of
576) younger than 10 years old; 81% (145 of 178),
10 to 19 years; 63% (98 of 156), 20 to 29 years;
25% (32 of 128), 30 to 39 years; 34% (34 of 100), 40
to 49 years; 54% (57 of 106), 50 to 59 years; 56%
(38 of 68), 60 to 69 years; 68% (47 of 69), older
than 70 years. Culture-positive persons under 20
years of age, especially children under 10 years
of age, were more likely to have symptoms than
other age groups. Intermediate rates of
symptom-free persons with positive stool
cultures occurred in young adults (20 to 29 years
of age) and the elderly (70 years of age), while the
highest rates of stool-positive, symptom-free
persons were adults, especially those between 30
and 49 years of age. In terms of pathogen
virulence, we did not find significant differences
in the distribution of stx subtypes and PFGE
genotypes between strains shed by symptomatic
and asymptomatic persons. These results
suggest that the rate of symptom-free STEC
O157:H7 shedding may be associated with age
rather than organism-related factors. Possible
age-related host factors that could influence the
presence of STEC O157:H7 in the stools of
symptom-free persons include qualitative and
quantitative differences in intestinal cross-
reactive antibodies against STEC O157:H7,
intestinal bacterial flora, or the sensitivity to Stx
toxins between children and adults. Further
investigations will be required to determine the
relative importance of these and other host
factors. Our finding of a high rate of
asymptomatic shedding in adults may suggest
the  potential for secondary transmission of the
bacteria from symptom-free STEC O157:H7-
shedding adults to healthy children.
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Streptococcus pyogenes Erythromycin
Resistance in Italy
To the Editor: Streptococcus pyogenes resistance
to erythromycin began to emerge as a serious
problem worldwide in the early 1990s. In some
areas in Italy, 30% to 40% of strains have beome